Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot Germany

Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Therapielinie 3 – adjuvante Immuntherapie (Pembrolizumab), ambulant

Raw json | Download

{
  "resourceType" : "EpisodeOfCare",
  "id" : "TherapieliniePembroAdjuvant",
  "meta" : {
    "profile" : [
      🔗 "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-line"
    ]
  },
  "language" : "de",
  "text" : {
    "status" : "extensions",
    "div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: EpisodeOfCare TherapieliniePembroAdjuvant</b></p><a name=\"TherapieliniePembroAdjuvant\"> </a><a name=\"hcTherapieliniePembroAdjuvant\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-onko-therapy-line.html\">Onkologische Therapielinie</a></p></div><blockquote><p><b>Onkologische Therapieintention (Extension)</b></p><ul><li>hauptintention: <span title=\"Codes:{http://snomed.info/sct 373846009}\">Adjuvant - intent</span></li><li>phase: <span title=\"Codes:{http://snomed.info/sct 1345242003}\">Maintenance antineoplastic therapy</span></li></ul></blockquote><p><b>EnLiST-Linien-Segment (Extension)</b>: <code>https://bih-cei.de/fhir/therapieziele-onkologie/sid/enlist-line</code>/mamma-baumann-elot-1</p><p><b>EnLiST-Zählstatus (Extension)</b>: <span title=\"Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-countable counted}\">Zählt in der LoT-Zählung</span></p><p><b>Therapielinie – Medikationsverordnung (Extension)</b>: <a href=\"MedicationRequest-MedicationRequestPembroAdjuvantMamma.html\">MedicationRequest: extension = Same LoT; status = active; intent = plan; category = Tumor board Consult note; medication[x] = </a></p><p><b>status</b>: Active</p><p><b>type</b>: <span title=\"Codes:{http://snomed.info/sct 76334006}\">Ambulante adjuvante Immuntherapie – Pembrolizumab-Monotherapie</span></p><h3>Diagnoses</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Condition</b></td><td><b>Role</b></td><td><b>Rank</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Condition-ConditionMamma.html\">Condition Bösartige Neubildung: Oberer äußerer Quadrant der Brustdrüse</a></td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/diagnosis-role CC}\">Chief complaint</span></td><td>1</td></tr></table><p><b>patient</b>: <a href=\"Patient-PatientinMamma.html\">Sabine Baumann  Female, DoB: 1977-06-24</a></p><p><b>managingOrganization</b>: <a href=\"Organization-Tumorboard.html\">Organization Zertifiziertes Brustzentrum Musterklinik</a></p><p><b>period</b>: 2026-04-24 --&gt; (ongoing)</p><p><b>careManager</b>: <a href=\"Practitioner-OnkologinMamma.html\">Practitioner Katrin Musterarzt </a></p></div>"
  },
  "extension" : [
    {
      "extension" : [
        {
          "url" : "hauptintention",
          "valueCodeableConcept" : {
            "coding" : [
              {
                "system" : "http://snomed.info/sct",
                "code" : "373846009",
                "display" : "Adjuvant - intent"
              }
            ]
          }
        },
        {
          "url" : "phase",
          "valueCodeableConcept" : {
            "coding" : [
              {
                "system" : "http://snomed.info/sct",
                "code" : "1345242003",
                "display" : "Maintenance antineoplastic therapy"
              }
            ]
          }
        }
      ],
      "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-intent"
    },
    {
      "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-line-segment",
      "valueIdentifier" : {
        "system" : "https://bih-cei.de/fhir/therapieziele-onkologie/sid/enlist-line",
        "value" : "mamma-baumann-elot-1"
      }
    },
    {
      "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-countable",
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-countable",
            "code" : "counted",
            "display" : "Zählt in der LoT-Zählung"
          }
        ]
      }
    },
    {
      "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-line-medication-request",
      "valueReference" : {
        🔗 "reference" : "MedicationRequest/MedicationRequestPembroAdjuvantMamma"
      }
    }
  ],
  "status" : "active",
  "type" : [
    {
      "coding" : [
        {
          "system" : "http://snomed.info/sct",
          "code" : "76334006",
          "display" : "Immunological therapy"
        }
      ],
      "text" : "Ambulante adjuvante Immuntherapie – Pembrolizumab-Monotherapie"
    }
  ],
  "diagnosis" : [
    {
      "condition" : {
        🔗 "reference" : "Condition/ConditionMamma"
      },
      "role" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/diagnosis-role",
            "code" : "CC",
            "display" : "Chief complaint"
          }
        ]
      },
      "rank" : 1
    }
  ],
  "patient" : {
    🔗 "reference" : "Patient/PatientinMamma"
  },
  "managingOrganization" : {
    🔗 "reference" : "Organization/Tumorboard"
  },
  "period" : {
    "start" : "2026-04-24"
  },
  "careManager" : {
    🔗 "reference" : "Practitioner/OnkologinMamma"
  }
}